| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Eli Lilly & Co (LLY) has 20 insiders with recent SEC Form 4 filings, including 0 buys and 96 sells. LLY is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 92.18M | $89.87B | - | |
| CEO | 515.2K | $502.27M | - | |
| VP | 137.5K | $134.04M | - | |
| Dir | 75.1K | $73.22M | - | |
| Dir | 55.5K | $54.08M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | Lilly Endowment Inc | - | Sell | 292,148 | $1,103.48 | $322,380,730.45 | - | -16.0% | - | |
| Jan 5, 2026 | Lilly Endowment Inc | - | Sell | 1,390 | $1,085.01 | $1,508,165.29 | - | -11.0% | - | |
| Dec 29, 2025 | Lilly Endowment Inc | - | Sell | 3,593 | $1,085.04 | $3,898,530.76 | - | -17.8% | - | |
| Dec 24, 2025 | Lilly Endowment Inc | - | Sell | 2,629 | $1,085.17 | $2,852,919.82 | - | -16.2% | - | |
| Dec 23, 2025 | Lilly Endowment Inc | - | Sell | 240 | $1,085.04 | $260,409.12 | - | -15.0% | - | |
| Nov 25, 2025 | Lilly Endowment Inc | - | Sell | 15,632 | $1,109.30 | $17,340,624.51 | - | -4.6% | - | |
| Nov 25, 2025 | Lilly Endowment Inc | - | Sell | 147,061 | $1,095.35 | $161,082,639.62 | - | -4.6% | - | |
| Nov 24, 2025 | Lilly Endowment Inc | - | Sell | 142,307 | $1,068.52 | $152,058,090.84 | - | -1.1% | - | |
| Nov 21, 2025 | Lilly Endowment Inc | - | Sell | 105,326 | $1,058.66 | $111,504,097.67 | - | -3.4% | - | |
| Nov 20, 2025 | Lilly Endowment Inc | - | Sell | 37,148 | $1,051.66 | $39,067,116.63 | - | -2.2% | - |